Image of COVID-19 virus

We've created this area for all COVID-19 information relevant to clinical trials we have gathered.

In line with the national guidance and emphasis on the safety and well-being of patients, research participants and their families, and health care professionals, researchers and other staff involved in patient care and research, ACTA strongly supports the continuation of investigator-led trials, where it is safe to do so, and with due consideration to any protocol amendments appropriate for the current COVID-19 pandemic.  

Subscribe to the ACTA newsletter if you would like to receive updates to guidance and other key information about clinical trials and COVID-19.

Latest News

Latest Events